$2.5 Billion Deal: Bristol-Meyers agrees to buy Inhibitex

 

Bristol-Myers Squibb Co. (NYSE: BMY) announced during morning trading in the stock market today that it will buy Alpharetta, Ga. based Inhibitex, Inc. (NASDAQ: INHX) for nearly $2.5 billion. Pending approval of the boards of directors of both companies, INHX is up over 140% today and over 500% since our first alert on INHX on

Continue Reading →
0

Inhibitex, Inc. (NASDAQ: INHX) Breaks 1,000% For Us

Originally Posted November 4th!

 

buy penny stocks, penny stocks, penny stock alerts, hot penny stocks, hottest penny stocks, best penny stocks

Inhibitex, Inc. (INHX)

Inhibitex, Inc. was upgraded by Deutsche Bank Thursday to a “buy” rating.

Inhibitex, Inc. closed Thursday at $3.96

Target Your Profits Higher!

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR BLOG POST.

Visit AimHighProfits.com to learn more about ...

Continue Reading →
0

Nov. 4: Don’t Inhibit Your Profits

Penny Stock To Watch: Inhibitex, Inc. (NASDAQ:INHX)

Inhibitex, Inc., a biopharmaceutical company, focuses on the development of differentiated anti-infective products to prevent or treat serious infections, primarily shingles and chronic infections caused by hepatitis C virus (HCV). Its antiviral product candidates include FV-100, an orally available nucleoside analogue prodrug, which is in Phase II trials for the treatment of herpes zoster or shingles; and INX-189, a HCV nucleoside polymerase inhibitor that ...

Continue Reading →
0